Jump to content
RemedySpot.com

UK conference report

Rate this topic


Recommended Posts

Guest guest
Posted

London Conference

Here is my report from the Invest in ME conference in London that took place on

May 24, 2010. This report is my attempt to communicate to others - to those

patients who could not attend (including my daughter) - what I saw and heard. I

am aware that this report reflects my own bias.

This is the fourth year that I have attended the Invest in ME conference in

London. The guiding lights of this effort are and Pia Simpson. These

dedicated individuals work tirelessly to make this conference happen. Their

hospitable and generous presence is felt everywhere, and I cannot imagine a

CFS/ME speaker having a better platform from which to make a presentation.

The one-day conference takes place in a beautiful lecture hall at the very edge

of St. Park. During breaks you can go out and sit in the sun on a park

bench and see the world go by. The hall seats 230 people. Each year this

conference grows in number, and this year the hall was packed – mostly with

patients and patient advocates. Soon the sponsors will have to find a bigger

venue. Each year the appropriate government and public health officials are

invited to attend and to make a contribution - and each year no one shows up. At

least they show a great consistency. (In the UK one is startled by what the NHS

does not provide for the citizens of this country. The health care for CFS/ME is

Kafkaesque and anyone interested in government run health care should take a

good look at this situation and disabuse themselves of their utopian dreams. The

situation is pathetic and very sad for the patients, who are desperate.)

Invest in ME invites the top medical or research practitioners to present at

this conference. Surprisingly (or not surprisingly) the participants are

increasingly American researchers and doctors. The all-day conference delivers a

disciplined and hard-hitting set of lectures, one after another. It is an

exhausting but rewarding day and the audience member has a front row seat to the

most current issues in CFS/ME, warts and all. In the past I have seen Garth

Nicholson, Myhill, Chia, Kenny de Meirleir, A. Lerner, Basant

Puri and Kerr. The lectures are usually 45 minutes long and the day is

broken into several sections with two tea breaks and a lunch break. A fine lunch

is served. During the breaks conversation is encouraged and it is possible to

pigeonhole the speakers.

The concept behind this conference is healthier and more focused than the

semi-annual meetings in the US. These US conferences, of which I have attended

two, are four days long and have a great amount of " filler " or academic cannon

fodder. The sponsors try to please everyone and in the process please no one.

The viewer gets none of this feeling at the Invest in ME conference.

Mondays lectures started early with Dr. Leonard . He is a good choice to

get the day going. I have heard Dr. speak a number of times and each time

he is better. He has been previously well received at his conference and for

good reason. He presents precise and well-organized statistical information

attempting to define the parameters of CFS/ME in a legible and understandable

fashion. Given the history of CFS/ME and its various confusions, this is not an

easy task. Along the way, he delves into subject matter that is quite

surrealistic, often bizarre and funny. Dr. Leonard works is a disciplined way,

mostly on his own, out of De University in Chicago. He strives towards

clarity regarding the language and definitions of CFS, and he is appreciated and

respected by a growing number of people.

Dr. 's inclinations and work can be gleaned from the internet. This is true

of all the speakers. My intention in writing this report is less to detail the

contents of the lectures and more to give a feeling about the conference from my

perspective. Things are changing with rapid dissemination of information

worldwide and personally, I did not expect to learn a whole bunch of useful

items that I did not already know. There were a few tidbits that I will include

in this report.

The second presentation was a solid academic talk by Nora Chapman from the

University of Nebraska. I imagine that the science of this talk passed over the

head of most of the audience, including mine. Chapman and her associates have

demonstrated that selection of defective enterovirus in heart and other tissues

leads to persistent infections despite active antiviral immune responses. Paired

with this lecture was Dr. Chia, who also works with enteroviruses. Dr. Chia

was back for the third straight year and he gave updated research information,

including case studies, enumerating his belief that enteroviruses are a major

causes in CFS/ME. Dr. Chia strikes a nice balance with his research ideas and

his treatment possibilities. In this case, he spoke at length about Equilibrant

(Oxymatrine) and its effectiveness in about half of his CFS patients. As he

likes to point out, this is a quite a high percentage of success for any CFS

protocol. Dr. Chia lectures can be seen online or on DVDs. Cort has

several good interviews of and discussions with Dr. Chia on his site. Dr. Chia

collaborates with his son on research. This year had to attend

classes at the U of Southern California where he is in pharmaceutical school.

Among other things he wants to learn and lobby for the development of

anti-enteroviral drugs. I was hoping that could meet my son , who is

about his age. was attending the conference and doing a little filming.

Maybe next year, the two can meet.

After the morning break, Cheney gave a lecture on oxygen toxicity and diastolic

dysfunction. Cheney's big problem was squeezing his usual three-hour lecture

into 45 minutes - and I can say that he did not do a good job of this. Twenty

minutes into the lecture I turned to my son and said that Dr. Cheney was

proceeding as if he had three hours - and that he had better speed it up. He

didn't and the consequence was that Dr. Cheney had to just stopped in the middle

of his lecture. However, it was not a big problem as any 45-minute slice of Dr.

Cheney is worth its weight in gold, and this day was no exception. Dr. Cheney is

a quite fantastic fellow. This was his first appearance at this UK conference.

Most of what he presented can be culled from his research website or from his

recent DVD from April 2009. Dr. Cheney gives credence to the new discovery of a

retrovirus. After all, Dr. Cheney has long believed that a retrovirus could be

at the center of this disorder. In his lecture, Dr. Cheney indicated that 38 of

47 consecutive patients in his practice were XMRV positive by culture testing at

VIP lab.

Kerr gave one of his exquisite low-key barely audible presentations. He

plows along in his genetic work, this time speaking on his continuing work to

subtype CFS by SNPs. In a nice bit of symmetry his slides matched his

inaudibility - and they were completely washed out and unviewable. What was with

this? I guess under current circumstances he was embarrassed to be at this

conference and wished he were somewhere else. Dr. Kerr used to do very important

work. Each year he seems to have less funding. In the past, at the end of his

lecture, he would show his band of researchers, shrinking magnificently each

year. This time I noticed that he didn't show the usual picture of his

colleagues - so I guess he doesn't have any. This sophisticated research is

fueled by cash and it seems to be drying up. Certainly the UK government gives

him nothing. One gets the feeling that the research of this lonely aspirant

languishes. He was going to fetch up with the WPI but I wonder what happened to

that? Long ago it was my suggestion that Dr. Kerr move to the US where he could

make a real contribution to CFS/ME research instead of stalling out. Surely he

knows that there are a lot of Brits living in the US and if he moved to

Minneapolis I would take him to Brit's Tavern for a Speckled Hen.

Klimas spoke on various immune markers. I prefer Kerr's quietness or

's dour seriousness to Klimas' happy optimism. She seems to be a " real

professional " – full of self-importance, weak research and false promises. I

would like to see something substantial come from her lab but I don't think I

will ever see it and now she has put her emphasis in running her own clinic. I

think the CFS/ME patients need more hard science research, not necessarily more

clinics. All this makes one suspicious of this person's intention.

Towards the end of the day, things heated up a bit. Brigitte Huber gave a talk

on her HERV-K18 research and then added a coda on XMRV. She did an unexpected

and gratuitous job of sandbagging Judy Mikovits, who was the next speaker. Huber

methodically went through her recent XMRV " study " , explaining in her officious

voice that her PCR test was the " assay of choice " and " very sensitive " . She

tested 228 samples, 112 from Levine, 105 from in Chicago, and 11

from the HHV6 foundation. Then she put up a slide with red letters that said,

" All samples were negative for XMRV integrase " .

Huber said, " We cannot see in our patients XMRV like in the Science article " .

In a further confounding maneuver she hinted or charged that the WPI study was

" contaminated " . This charge needs to be challenged, as it is a lie. As she was

leaving the lectern Huber said in a wonderfully disingenuous voice (to no one

special, but I suppose it was directed towards Judy Mikovits), " Sorry " . It was a

revealing and weasily moment.

To me it is becoming obvious that certain people, especially doctors who have

been treating patients unsuccessfully for years with half-baked treatments, or

researchers who are connected to the academic research money tit, are trying to

sink Mikovits and the WPI. This is not science; this is venality. This negative

reaction has little to do with whether XMRV has any validity or not. That is a

separate issue and there are two sides to the argument; and it needs to be

fought out according to established scientific methods. I think that certain

critics sense, perhaps correctly, that soon they might be out of a job.

The day before the conference, there was a brain storming session with the

various participants at this conference – Cheney, Chia, Huber, ,

Whittemore, Chapman. It is a great idea and discussion/disagreement (sometimes

fierce) is often a necessary and useful result of such exchanges. In this

afternoon session, Huber launched an attack on Mikovits. Mikovits did her usual

job of defending herself. Huber left the group early (maybe to go shopping?). As

she left Huber promised that she would not create a controversy by revealing her

study results the next day.

Overnight Huber changed her mind, honest soul that she is, and made her awkward

revelation. It was all quite unseemly, and did not fit the tone and tenor of

this conference - which is heavily ladened with sick patients, hanging on by a

thread. They make a great sacrifice to get to this conference, but not to hear

this kind of shit. After all this is really not a scientific conference, and

this nice bit of spite was entirely out of place.

When was the last time that Huber gave one iota of thought about CFS patients? I

can tell you exactly – it was… Never!

I watched this with fascination, realizing that Huber in her righteousness had

put her head on a block and asked to have her face kicked in. It was a great

setup, a " once in a lifetime situation " , and Mikovits came through big-time,

doing what she needed to do. She remained calm (inside she must have been

boiling) and delivered a splendid lecture (the best that I have seen her do) and

demolishing Huber. The effect was that Huber shrank down to the size of a pea. I

had talked to Mikovits the day before about Huber and advised her in general to

disregard her critics and just roll over this woman (not that Mikovits spends

one moment listening to me). Some critics need to be rolled and this was just

what happened. At the end of her lecture, Mikovits got a loud and sustained

applause showing deeply felt appreciation.

The moderator of the conference once again was Malcolm Hoover, who represents

the best of the UK ME doctors and researchers. Dr. Hooper is known for the

Hoover files, which are included on the conference DVD to be released in several

weeks. Dr. Hoover has an easygoing manner, moves things long nicely, keeps the

conversation focused and gives helpful commentary when necessary. This man

obviously has multiple gifts.

Invest in ME's primary idea (I believe) in creating this conference was to bring

the most recent research and treatment information to the UK, a tidal backwater

in regards to recognition of the seriousness of this disease (not that the US is

much better). Beyond this they want to facilitate these personalities to sit

down and talk together and to share their ideas. In general CFS doctors and

researchers are a lonely band of folks, comfortable and happy with their

isolation. In other words their social skills are limited, especially in

relating to each other. In the last few years, things have gotten much better in

this regard, mainly due to this conference and a few other " retreats " of CFS/ME

notables, supported by private donors.

The high-mindedness of these talks always disintegrates at the end of the day

with a plenary session where patients and patient advocates plead for treatment

advice – treatment readily available in the US and denied the patients in the

US. (Whether these treatments work or not is another conversation.)

The question is why, with so much of this information readily available, one

would bother to attend this conference. It is a good question. My answer is that

this conference allows me to get a sense of the direction of things, the

" zeitgeist " of this field - and also to talk directly to the participants in the

more informal parts of the conference. Unexpected things happen and one picks up

bit of information or has other items reinforced. For instance, I got to hear

Dr. Chia talk for a few hours at dinner. What a pleasure this was! I got to

watch him " interrogate " a patient advocate about their patient. Dr. Chia seeks

out particular symptoms and circumstances that occur at the onset of the

illness. It is a bit like 19th century medicine - but CFS/Me is a 19th century

disease. And this form of questioning yields answers for Dr. Chia.

I have been inclined towards Dr. Chia since I first heard him speak. He has a

forthright, unadorned quality that is makes you pay attention. Dr. Chia has

worked in the trenches for twenty or more years, learning about this illness the

hard way, and developing his own resources to maintain and increase his

research. Dr. Chia is definitely onto something " specific " - in a field where so

much is elusive and speculative. If I were going to give a newcomer to this

field a bit of advice (and I do not have a whole lot to give) I would recommend

learning about Dr. Chia, his testing and his treatment. It is a good bet, and

perhaps you will get lucky.

At another point, I got to hear Dr. Cheney give an informal mini-lecture on

parts of his protocol: artusenate, minocycline, wormwood, and cell signaling

factors. In regards to this last item Dr. Cheney related his enthusiasm about a

new gel that he has made from afterbirth material. Citing studies on hamsters,

Cheney described a process where non-stem cell material is extracted from stem

cells and injected back into the hamsters, curing them as if it were stem cells.

Dr. Cheney has made a similar gel from human afterbirth that gets a very strong

reaction on his Echo machine, much stronger than any existing CSF. He is very

excited about this.

I observed several individuals from the WPI doing their presentations and

establishing connections. I can assure you that the announcement of the demise

of the WPI is premature. They are moving faster than ever. The WPI is on a

trajectory that will leave its critics in the dust. While others quibble over

this and that, and lay traps to distract them, the WPI are putting all that

aside and focusing on the task at hand. More specific and accurate testing is

close at hand, as is means to track improvement in patient's immune status, as

well as clinical trials using various existing anti-retroviral drugs. Peptide T

is still in the picture. (Another non-WPI source indicates that GCMAF might be a

player.) (Time will tell in all this and the nay-sayers have put great effort

into trying to cut off the funding and grants for the WPI. In this they have

been somewhat successful, leaving it to the rest of us to do what we can to

increase funding for this important scientific research.)

The WPI is in the process of projecting and clarifying their mission and of

making collaborative connections with the international community in a manner

that has never been seen before in this disease.

This was a great conference.

Chris

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...